<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>vortioxetine Archives - Gateway Psychiatric</title>
	<atom:link href="https://www.gatewaypsychiatric.com/tag/vortioxetine/feed/" rel="self" type="application/rss+xml" />
	<link></link>
	<description>Excellent Psychiatric Care</description>
	<lastBuildDate>Wed, 07 Jul 2021 13:52:01 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://i0.wp.com/www.gatewaypsychiatric.com/wp-content/uploads/2013/06/favicon2.png?fit=32%2C32&#038;ssl=1</url>
	<title>vortioxetine Archives - Gateway Psychiatric</title>
	<link></link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">70562394</site>	<item>
		<title>Vortioxetine for Cognitive Impairment in Depression</title>
		<link>https://www.gatewaypsychiatric.com/vortioxetine-for-cognitive-impairment-in-depression/</link>
		
		<dc:creator><![CDATA[Peter Forster]]></dc:creator>
		<pubDate>Mon, 08 Feb 2016 12:41:28 +0000</pubDate>
				<category><![CDATA[Major Depression]]></category>
		<category><![CDATA[Treatments of Depression]]></category>
		<category><![CDATA[cognition]]></category>
		<category><![CDATA[cognitive function]]></category>
		<category><![CDATA[depression]]></category>
		<category><![CDATA[treatments of depression]]></category>
		<category><![CDATA[vortioxetine]]></category>
		<guid isPermaLink="false">https://www.gatewaypsychiatric.com/?p=9951</guid>

					<description><![CDATA[<p>Takeda and Lundbeck announced that the Food and Drug Administration (FDA)&#8217;s Psychopharmacologic Drug Advisory Committee (PDAC) voted to support the efficacy of vortioxetine (Brintellix) for treating cognitive dysfunction in adults with major depressive disorder (MDD). The advisory committee also reviewed evidence to suggest that cognitive dysfunction in people with major depressive disorder was an appropriate target for treatment. Several recent ... </p>
<div><a href="https://www.gatewaypsychiatric.com/vortioxetine-for-cognitive-impairment-in-depression/" class="more-link">Read More</a></div>
<p>The post <a href="https://www.gatewaypsychiatric.com/vortioxetine-for-cognitive-impairment-in-depression/">Vortioxetine for Cognitive Impairment in Depression</a> appeared first on <a href="https://www.gatewaypsychiatric.com">Gateway Psychiatric</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">9951</post-id>	</item>
		<item>
		<title>Vortioxetine a New Antidepressant</title>
		<link>https://www.gatewaypsychiatric.com/vortioxetine-a-new-antidepressant/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Fri, 25 Jul 2014 15:11:56 +0000</pubDate>
				<category><![CDATA[Treatments of Depression]]></category>
		<category><![CDATA[antidepressant]]></category>
		<category><![CDATA[depression]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[vortioxetine]]></category>
		<guid isPermaLink="false">https://www.gatewaypsychiatric.com/?p=7683</guid>

					<description><![CDATA[<p>Vortioxetine (Brintellix) is a new antidepressant that has a range of effects on serotonin receptors, making it different from selective serotonin reuptake inhibitors (SSRIs), the most common type of antidepressants, which work only on the serotonin transporter. Researcher Johan Areberg et al. reported at the 2014 meeting of the American Psychiatric Association that the drug is an antagonist at receptors ... </p>
<div><a href="https://www.gatewaypsychiatric.com/vortioxetine-a-new-antidepressant/" class="more-link">Read More</a></div>
<p>The post <a href="https://www.gatewaypsychiatric.com/vortioxetine-a-new-antidepressant/">Vortioxetine a New Antidepressant</a> appeared first on <a href="https://www.gatewaypsychiatric.com">Gateway Psychiatric</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">7683</post-id>	</item>
	</channel>
</rss>
